News

Sep 19
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over

Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with “60 Minutes” that aired on Sunday. Moderna Inc. MRNA, -8.98% fell 9.2%, Pfizer Inc. PFE, -1.79% was down 1.7% and its German partner BioNTech SE BNTX, -8.46% was down 8.4%. Novavax Inc. […]

Sep 19
Precious Metals Monday 19-09-2022

Metals Under Pressure Ahead of FOMC It’s been a soft start to the week for the metals market as fresh strength in USD sees gold and silver both sold over the European open on Monday. Traders’ focus this week will be fixed firmly on the FOMC on Wednesday. The US Dollar was seen back in […]

Sep 19
Micro Bitcoin Futures (MBT1!), H4 Potential For Bullish Rise

Type: Bullish Rise Key Levels:Resistance: 17425Pivot: 18560Support: 19370 Preferred Case:On the H4, price has broken the swing low, we’re looking for a break out of 18560 levels where the 61.8% projection sits. If bearish momentum continues, it should bring price to 17425 where the 78.6% projection sits Alternative Scenario:Alternatively, price could pull back to the […]

Sep 19
Does the Ethereum Merge offer a new destination for institutional investors?

Last week’s Merge was the “most significant development in the history of the Ethereum network,” according to Fidelity Digital.  And from a purely technical standpoint, the blockchain network’s transition from a proof-of-work (PoW) to a proof-of-stake (PoS) consensus mechanism was a marvel. Widely compared to changing a jet engine mid-flight, the software upgrade proceeded with […]

Sep 19
Dow opens nearly 250 points lower as investors await Wednesday Fed decision

U.S. stocks opened lower on Monday, on track for a third day of declines, as investors await a decision from the Federal Reserve, which is expected to deliver another jumbo interest-rate hike on Wednesday. The S&P 500 SPX, -0.33% is down 31 points, or 0.8%, to 3,841. The Dow Jones Industrial Average DJIA, -0.24% retreated […]

Sep 19
UPDATE: Theravance Biopharma plans $250 million capital return program; stock jumps 3% premarket

Theravance Biopharma Inc. TBPH, +3.03% said Monday its board has authorized a $250 million capital return program, that includes buying back its own stock from GSK Plc GSK, -0.79%. The company will purchase GSK’s entire holdings of about 9.6 million shares at $9.75 a share with the closing expected Tuesday. The company also plans to […]